The routine use of antibiotics in animal agriculture is a leading cause of antibiotic resistance, that without major change, will become a leading cause of death by 2050 Public Health Campaigns, ...

Clinical outcomes among adult inpatients were no worse when broad-spectrum antibiotic therapy was delayed vs started early, challenging the belief that overly broad-spectrum empiric antibiotic ...

Despite guidelines stating otherwise, clinicians continue to prescribe inappropriate antibiotics to hospitalized patients with skin and soft tissue infections (SSTIs), raising costs and increasing ...

A device to quickly detect bacteria and antibiotic resistance is being developed by a consortium of Portuguese public and private entities. “We’re talking about a portable device that, with a simple ...

Researchers believe they have identified a new class of antibiotics, nearly three decades since the last new one came to market. Teams at McMaster University in Ontario, Canada and the University ...

Clinical outcomes among adult inpatients were no worse when broad-spectrum antibiotic therapy was delayed vs started early, challenging the belief that overly broad-spectrum empiric antibiotic therapy ...

"Antibiotic resistance is one of the major threats to modern medicine," said Professor Ronan McCarthy, who led the research at Brunel University of London's Antimicrobial Innovations Center.

Traditional composting often fails due to low lignocellulose degradation efficiency and the persistence of pathogens and antibiotic resistance genes (ARGs). Additionally, the use of antibiotics ...

The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global ...

Antibiotic use and allergy risk: The study found that infants and toddlers who were most frequently prescribed antibiotics had a higher risk of developing food allergies, hay fever, and asthma ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...